A novel approach to the antimicrobial activity of maggot debridement therapy

Journal of Antimicrobial Chemotherapy

Volumn 65, Issue 8, 2010, Pages 1646-1654

  Andersen, Anders S ^a,b,c   Sandvang, Dorthe ^b   Schnorr, Kirk M ^b   Kruse, Thomas ^b   Neve, Søren ^b   Joergensen, Bo ^c   Karlsmark, Tonny ^c   Krogfelt, Karen A ^a  

^a STATENS SERUM INSTITUT   (Denmark)

^b NOVOZYMES A S   (Denmark)

^c BISPEBJERG HOSPITAL   (Denmark)

Author keywords

Antimicrobial peptides; Defensins; Lucilia sericata; MRSA; Wounds

Indexed keywords

ATTACIN; CHITIN BINDING PROTEIN; CUTICLE PROTEIN; DEFENSIN; FERRITIN HEAVY CHAIN LIKE PROTEIN; FERRITIN LIGHT CHAIN LIKE PROTEIN; HYBRID PROTEIN; INSECT PROTEIN; LECTIN; LECTIN ALPHA SUBUNIT; LUCIFENSIN; LYSINE RICH LYSOZYME 2; LYSOZYME 1; PEPTIDOGLYCAN RECOGNITION PROTEIN; PHORMICIN; POLYPEPTIDE ANTIBIOTIC AGENT; RECOMBINANT PROTEIN; SAPECIN; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; COMPLEMENTARY DNA;

AFFINITY CHROMATOGRAPHY; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; DNA LIBRARY; ESCHERICHIA COLI; GLYCOPEPTIDE INTERMEDIATE STAPHYLOCOCCUS AUREUS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; MAGGOT; MAGGOT THERAPY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICRODISSECTION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SALIVARY GLAND; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS CARNOSUS; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES; TECHNIQUE; TRANSPOSON; TRANSPOSON ASSISTED SIGNAL TRAPPING; ANIMAL; DIPTERA; DNA SEQUENCE; DRUG EFFECTS; GENE EXPRESSION; GENETICS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ISOLATION AND PURIFICATION; LARVA; MICROBIAL SENSITIVITY TEST; MOLECULAR CLONING; MOLECULAR GENETICS;

ANIMALS; ANTI-BACTERIAL AGENTS; CHROMATOGRAPHY, AFFINITY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CLONING, MOLECULAR; DEFENSINS; DIPTERA; DNA, COMPLEMENTARY; ESCHERICHIA COLI; GENE EXPRESSION; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; INSECT PROTEINS; LARVA; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; RECOMBINANT PROTEINS; SEQUENCE ANALYSIS, DNA;

EID: 77954728162     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkq165     Document Type: Article

References (48)

1. Baer WS. The treatment of chronic osteomyelitis with the maggot (larva of the blow fly). J Bone Joint Surg 1931; 13: 438.
2. Pechter EA, Sherman RA. Maggot therapy: the surgical metamorphosis. Plast Reconstr Surg 1983; 72: 567-70.
3. Sherman RA, Pechter EA. Maggot therapy: a review of the therapeutic applications of fly larvae in human medicine, especially for treating osteomyelitis. Med Vet Entomol 1988; 2: 225-30.
4. Dumville JC, Worthy G, Bland JM et al. Larval therapy for leg ulcers (VenUS II): randomised controlled trial. BMJ 2009; 338: b773.
5. Jaklic D, Lapanje A, Zupancic K et al. Selective antimicrobial activity of maggots against pathogenic bacteria. J Med Microbiol 2008; 57: 617-25.
6. Steenvoorde P, Jukema GN. The antimicrobial activity of maggots: in-vivo results. J Tissue Viability 2004; 14: 97-101.
7. Mumcuoglu KY, Miller J, Mumcuoglu M et al. Destruction of bacteria in the digestive tract of the maggot of Lucilia sericata (Diptera: Calliphoridae). J Med Entomol 2001; 38: 161-6.
8. Chambers L, Woodrow S, Brown AP et al. Degradation of extracellular matrix components by defined proteinases from the greenbottle larva Lucilia sericata used for the clinical debridement of non-healing wounds. Br J Dermatol 2003; 148: 14-23.
9. Bexfield A, Bond AE, Roberts EC et al. The antibacterial activity against MRSA strains and other bacteria of a <500Da fraction from maggot excretions/secretions of Lucilia sericata (Diptera: Calliphoridae). Microbes Infect 2008; 10: 325-33.
10. Bexfield A, Nigam Y, Thomas S et al. Detection and partial characterisation of two antibacterial factors from the excretions/secretions of the medicinal maggot Lucilia sericata and their activity against methicillin-resistant Staphylococcus aureus (MRSA). Microbes Infect 2004; 6: 1297-304.
11. Daeschlein G, Mumcuoglu KY, Assadian O et al. In vitro antibacterial activity of Lucilia sericata maggot secretions. Skin Pharmacol Physiol 2007; 20: 112-5.
12. Kerridge A, Lappin-Scott H, Stevens JR. Antibacterial properties of larval secretions of the blowfly Lucilia sericata. Med Vet Entomol 2005; 19: 333-7.
13. Thomas S, Andrews AM, Hay NP et al. The anti-microbial activity of maggot secretions: results of a preliminary study. J Tissue Viability 1999; 9: 127-32.
14. Harris LG, Bexfield A, Nigam Y et al. Disruption of Staphylococcus epidermidis biofilms by medicinal maggot Lucilia sericata excretions/secretions. Int J Artif Organs 2009; 32: 555-64.
15. van der Plas MJ, Jukema GN, Wai SWet al. Maggot excretions/secretions are differentially effective against biofilms of Staphylococcus aureus and Pseudomonas aeruginosa. J Antimicrob Chemother 2008; 61: 117-22.
16. Cazander G, van Veen KE, Bernards AT et al. Do maggots have an influence on bacterial growth? A study on the susceptibility of strains of six different bacterial species to maggots of Lucilia sericata and their excretions/secretions. J Tissue Viability 2009; 18:80-7.
17. Andersen AS, Joergensen B, Bjarnsholt T et al. Quorumsensing-regulated virulence factors in Pseudomonas aeruginosa are toxic to Lucilia sericata maggots. Microbiology 2010; 156: 400-7.
18. Huberman L, Gollop N, Mumcuoglu KY et al. Antibacterial substances of low molecular weight isolated from the blowfly, Lucilia sericata. Med Vet Entomol 2007; 21: 127-31.
19. Altincicek B, Vilcinskas A. Septic injury-inducible genes in medicinal maggots of the green blow fly Lucilia sericata. Insect Mol Biol 2009; 18: 119-25.
20. Vodovar N, Vinals M, Liehl P et al. Drosophila host defense after oral infection by an entomopathogenic Pseudomonas species. Proc Natl Acad Sci USA 2005; 102: 11414-9.
21. Freitak D, Wheat CW, Heckel DG et al. Immune system responses and fitness costs associated with consumption of bacteria in larvae of Trichoplusia ni. BMC Biol 2007; 5: 56.
22. Becker F, Schnorr K, Wilting R et al. Development of in vitro transposon assisted signal sequence trapping and its use in screening Bacillus halodurans C125 and Sulfolobus solfataricus P2 gene libraries. J Microbiol Methods 2004; 57: 123-33.
23. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor: Cold Spring Harbor Laboratory Press, 1989.
24. Walter MC, Rattei T, Arnold R et al. PEDANT covers all complete RefSeq genomes. Nucleic Acids Res 2009; 37: D408-11.
25. Frishman D, Albermann K, Hani J et al. Functional and structural genomics using PEDANT. Bioinformatics 2001; 17: 44-57.
26. Xu X, Jin F, Yu X et al. Expression and purification of a recombinant antibacterial peptide, cecropin, from Escherichia coli. Protein Expr Purif 2007; 53: 293-301.
27. Jin F, Dong X, Xu X et al. cDNA cloning and recombinant expression of the general odorant binding protein II from Spodoptera litura. Sci China C Life Sci 2009; 52:80-7.
28. Lehrer RI, Rosenman M, Harwig SS et al. Ultrasensitive assays for endogenous antimicrobial polypeptides. J Immunol Methods 1991; 137: 167-73.
29. Clinical and Laboratory Standards Institute. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically-Seventh Edition: Approved Standard M7-A7. CLSI, Wayne, PA, USA, 2006.
30. Tanji T, Shiraishi H, Natori S et al. Differential activation of the lectin and antimicrobial peptide genes in Sarcophaga peregrina (the flesh fly). Arch Insect Biochem Physiol 2008; 69: 189-98.
31. Ando K, Natori S. Molecular cloning, sequencing, and characterization of cDNA for sarcotoxin IIA, an inducible antibacterial protein of Sarcophaga peregrina (flesh fly). Biochemistry 1988; 27: 1715-21.
32. Mygind PH, Fischer RL, Schnorr KM et al. Plectasin is a peptide antibiotic with therapeutic potential from a saprophytic fungus. Nature 2005; 437: 975-80.
33. Gottlieb CT, Thomsen LE, Ingmer H et al. Antimicrobial peptides effectively kill a broad spectrum of Listeria monocytogenes and Staphylococcus aureus strains independently of origin, sub-type, or virulence factor expression. BMC Microbiol 2008; 8: 205.
34. Cerovsky V, Zdarek J, Fucik V et al. Lucifensin, the long-sought antimicrobial factor of medicinal maggots of the blowfly Lucilia sericata. Cell Mol Life Sci 2010; 67: 455-66.
35. National Committee for Clinical Laboratory Standards. Methods for Determining Bactericidal Activity of Antimicrobial Agents: Approved Standard M26-A. NCCLS, Wayne, PA, USA, 1999.
36. th Edn: Approved Standard M7-A5. NCCLS, Wayne, PA, USA, 2000.
37. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Susceptibility Testing: Twelfth Informational Supplement M100-S12. NCCLS, Wayne, PA, USA, 2002.
38. Gould IM. Antibiotic resistance: the perfect storm. Int J Antimicrob Agents 2009; 34 Suppl 3: S2-5.
39. Natori S, Shiraishi H, Hori S et al. The roles of Sarcophaga defense molecules in immunity and metamorphosis. Dev Comp Immunol 1999; 23: 317-28.
40. Imler JL, Bulet P. Antimicrobial peptides in Drosophila: structures, activities and gene regulation. Chem Immunol Allergy 2005; 86: 1-21.
41. Hetru C, Troxler L, Hoffmann JA. Drosophila melanogaster antimicrobial defense. J Infect Dis 2003; 187 Suppl 2: S327-34.
42. Jomori T, Natori S. Molecular cloning of cDNA for lipopolysaccharide-binding protein from the hemolymph of the American cockroach, Periplaneta americana. Similarity of the protein with animal lectins and its acute phase expression. J biol Chem 1991; 266: 13318-23.
43. Chen C, Billingsley PF. Detection and characterization of a mannan-binding lectin from the mosquito, Anopheles stephensi (Liston). Eur J Biochem 1999; 263: 360-6.
44. Yamamoto-Kihara M, Kotani E. Isolation and characterization of a C-type lectin cDNA specifically expressed in the tip of mouthparts of the flesh fly Sarcophaga peregrina. Insect Mol Biol 2004; 13: 133-40.
45. Ando K, Natori S. Inhibitory effect of sarcotoxin IIA, an antibacterial protein of Sarcophaga peregrina, on growth of Escherichia coli. J Biochem 1988; 103: 735-9.
46. Matsuyama K, Natori S. Mode of action of sapecin, a novel antibacterial protein of Sarcophaga peregrina (flesh fly). J Biochem 1990; 108: 128-32.
47. Bowling FL, Salgami EV, Boulton AJ. Larval therapy: a novel treatment in eliminating methicillin-resistant Staphylococcus aureus from diabetic foot ulcers. Diabetes Care 2007; 30: 370-1.
48. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 2002; 415: 389-95.